These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 21156026)

  • 1. Peptides that bind the HIV-1 integrase and modulate its enzymatic activity--kinetic studies and mode of action.
    Levin A; Benyamini H; Hayouka Z; Friedler A; Loyter A
    FEBS J; 2011 Jan; 278(2):316-30. PubMed ID: 21156026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between shiftide activity and HIV-1 integrase inhibition by a peptide selected from a combinatorial library.
    Armon-Omer A; Levin A; Hayouka Z; Butz K; Hoppe-Seyler F; Loya S; Hizi A; Friedler A; Loyter A
    J Mol Biol; 2008 Feb; 376(4):971-82. PubMed ID: 18201721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
    Gleenberg IO; Herschhorn A; Hizi A
    J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory profile of a LEDGF/p75 peptide against HIV-1 integrase: insight into integrase-DNA complex formation and catalysis.
    Al-Mawsawi LQ; Christ F; Dayam R; Debyser Z; Neamati N
    FEBS Lett; 2008 Apr; 582(10):1425-30. PubMed ID: 18331842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
    Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
    Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
    Li HY; Zawahir Z; Song LD; Long YQ; Neamati N
    J Med Chem; 2006 Jul; 49(15):4477-86. PubMed ID: 16854053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors.
    Chen X; Tsiang M; Yu F; Hung M; Jones GS; Zeynalzadegan A; Qi X; Jin H; Kim CU; Swaminathan S; Chen JM
    J Mol Biol; 2008 Jul; 380(3):504-19. PubMed ID: 18565342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tn5 transposase as a useful platform to simulate HIV-1 integrase inhibitor binding mode.
    Barreca ML; Ortuso F; Iraci N; De Luca L; Alcaro S; Chimirri A
    Biochem Biophys Res Commun; 2007 Nov; 363(3):554-60. PubMed ID: 17889829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification by phage display selection of a short peptide able to inhibit only the strand transfer reaction catalyzed by human immunodeficiency virus type 1 integrase.
    Desjobert C; de Soultrait VR; Faure A; Parissi V; Litvak S; Tarrago-Litvak L; Fournier M
    Biochemistry; 2004 Oct; 43(41):13097-105. PubMed ID: 15476403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 integrase complexes with DNA dissociate in the presence of short oligonucleotides conjugated to acridine.
    Pinskaya M; Romanova E; Volkov E; Deprez E; Leh H; Brochon JC; Mouscadet JF; Gottikh M
    Biochemistry; 2004 Jul; 43(27):8735-43. PubMed ID: 15236582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
    Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
    FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides derived from HIV-1 Rev inhibit HIV-1 integrase in a shiftide mechanism.
    Hayouka Z; Rosenbluh J; Levin A; Maes M; Loyter A; Friedler A
    Biopolymers; 2008; 90(4):481-7. PubMed ID: 18219678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The terminal (catalytic) adenosine of the HIV LTR controls the kinetics of binding and dissociation of HIV integrase strand transfer inhibitors.
    Langley DR; Samanta HK; Lin Z; Walker MA; Krystal MR; Dicker IB
    Biochemistry; 2008 Dec; 47(51):13481-8. PubMed ID: 18991395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.
    Neamati N; Hong H; Owen JM; Sunder S; Winslow HE; Christensen JL; Zhao H; Burke TR; Milne GW; Pommier Y
    J Med Chem; 1998 Aug; 41(17):3202-9. PubMed ID: 9703465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus type-1 reverse transcriptase by a novel peptide derived from the viral integrase.
    Oz Gleenberg I; Herschhorn A; Goldgur Y; Hizi A
    Arch Biochem Biophys; 2007 Feb; 458(2):202-12. PubMed ID: 17257575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel short peptide is a specific inhibitor of the human immunodeficiency virus type 1 integrase.
    de Soultrait VR; Caumont A; Parissi V; Morellet N; Ventura M; Lenoir C; Litvak S; Fournier M; Roques B
    J Mol Biol; 2002 Apr; 318(1):45-58. PubMed ID: 12054767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of the HIV-1 integrase enzymatic activity and cDNA integration by a peptide derived from the integrase protein.
    Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
    Biopolymers; 2010 Aug; 93(8):740-51. PubMed ID: 20517955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human immunodeficiency virus type I integrase by naphthamidines and 2-aminobenzimidazoles.
    Middleton T; Lim HB; Montgomery D; Rockway T; Tang H; Cheng X; Lu L; Mo H; Kohlbrenner WE; Molla A; Kati WM
    Antiviral Res; 2004 Oct; 64(1):35-45. PubMed ID: 15451177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein.
    Hayouka Z; Hurevich M; Levin A; Benyamini H; Iosub A; Maes M; Shalev DE; Loyter A; Gilon C; Friedler A
    Bioorg Med Chem; 2010 Dec; 18(23):8388-95. PubMed ID: 20974536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies.
    Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX
    Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.